表紙
市場調査レポート

世界の体外診断薬(IVD)市場レポート

Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition

発行 Koncept Analytics 商品コード 223486
出版日 ページ情報 英文 66 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
世界の体外診断薬(IVD)市場レポート Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition
出版日: 2015年12月11日 ページ情報: 英文 66 Pages
概要

世界の体外診断薬市場において、血糖モニタリングおよび臨床化学部門は比較的成熟し、安定しています。今後はオーダーメイド医療が増える傾向に伴い、分子診断学部門が厳しい規制措置を受けながらも大きく成長すると見込まれています。市場全体の成長を促進する要因としては、ジェネリック医薬品のマクロ経済的要因を別として、糖尿病患者の急増、医療関連のハイテク機器の売り上げ増、疾患の複雑性、心筋トロポニン測定の増加などが挙げられます。現在業界で特筆すべき傾向に、ビタミンD測定市場の新たな伸びや、ゲノム解読市場、腫瘍学におけるコンパニオン診断の活用、更に診断の重要性の高まりなどがあります。しかしながら、業界には依然として市場内にある狭い経済の壁、臨床検査サービスにおける医療費償還問題、IVDによる利益を減らす研究所開発検査、政府のIVD検査に対する規制および遺伝子検査での厳しい規制などといった課題があります。

当レポートでは、体外診断用医薬品(IVD)の世界市場について分析し、全体的な市場構造や成長促進要因、規制構造、競争環境、主要市場の動向、主要企業のプロファイルと戦略などの情報を盛り込むとともに、今後の市場動向についても推計して、その結果をお届けします。

第1章 体外診断薬(IDV):概要

  • IVD製品の種類
  • IVDテストの種類
  • 市場の分類
    • 技術別
    • エンドユーザー別
  • IVDの利用法
  • IVDのバリューチェーン

第2章 IVD市場分析

  • 世界市場
    • 市場価値
    • 地域別内訳
    • 技術種類別市場
    • 製品種類別市場
    • 検査部位別市場
  • 分子診断
    • 検査区域別
  • 免疫学的測定
  • 地域市場
    • 欧州
      • 市場価格
      • 国別内訳
    • 中国

第3章 市場のダイナミクス

  • 成長促進要因
    • 世界的な医療費の増加
    • 世界的な高齢者人口の増加
    • 糖尿病患者数の急激な増加
    • 世界的な国民総所得の増加
    • 医療用ハイテク機器の売り上げ増
    • 疾患の複雑性の増加
    • 心筋トロポニン測定の増加
  • 主要動向
    • ビタミンD測定市場−新たな成長部門
    • Illumina−ゲノム解読市場を支配
    • 診断の重要性の高まり
    • 腫瘍学におけるコンパニオン診断の活用
  • 課題
    • 市場内にめぐらされた狭い経済の壁
    • 遺伝子検査でさらに厳しくなった規制
    • IVDによる利益を減らす研究所開発検査
    • IVD検査に対する政府規制
    • 臨床検査サービスの範囲と医療費償還問題

第4章 競争環境

  • 世界市場
  • 部門別の競争状況
    • 臨床化学
    • 血糖検査
    • 微生物学
    • 血液学およびフローサイトメトリー
    • 分子生物学診断
    • 免疫学的測定
    • 細胞診断
  • 中国

第5章 企業プロファイル

  • Abbott Laboratories
    • 事業内容
    • 財務指標
    • 事業戦略
  • Siemens AG
    • 事業内容
    • 財務指標
    • 事業戦略
  • Roche Holdings AG
    • 事業内容
    • 財務指標
    • 事業戦略
  • Johnson & Johnson
    • 事業内容
    • 財務指標
    • 事業戦略

第6章 市場展望

  • 市場予測
  • 予測手法
    • 独立・従属変数
    • 相関分析
    • 回帰分析

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The diagnostic industry is widely classified into two types: In-vitro diagnostics and In-vivo diagnostics. In-vitro tests are executed in glass test tubes, while In-vivo diagnostics tests are executed inside a patient's body. IVD products are indeed designed and produced for collecting samples derived from the patient's body and scrutinizing them outside, which are commonly conducted in hospitals, clinics and labs and in personal settings. Apart from the application of IVDs in medical diagnosis and health screening such as checking blood of signs for infections, or urine for the presence of glucose, they are also used in genetic testing, genomics, veterinary diagnostics, food testing, environmental testing, and research.

As per the "Global IVD market report", market segments such as blood glucose monitoring and clinical chemistry are relatively mature and stable. However, with growing personalized medical treatment trend, molecular diagnostics market is expected to grow significantly with strict regulatory measures.

The key factors driving the market growth apart from generic macro-economic factors include accelerating diabetic population, increasing sales of medical technological devices, increasing complexity of diseases, and development of cardiac troponin assays. Some of the noteworthy trends observed in the industry are newly growing vitamin D testing market, genome sequencing market, usage of companion diagnostics in oncology, and increased importance of diagnostics. However, the industry remains exposed to certain challenges such as narrow economic moats in diagnostic market, reimbursement issues in clinical laboratory services, laboratory-developed tests waning IVD profits, and government regulation for IVD tests and stringent in genetic based tests.

The report provides a comprehensive study of global in-vitro diagnostic market covering regional markets and major segments. The competition in the global in-vitro diagnostic market is highly amalgamated with large players like Abbott, Siemens, Roche and Johnson and Johnson. All these companies have been profiled in the present report highlighting their key financials and business strategies for their long term growth.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Table of Contents

1. Overview

  • 1.1 Types of IVD Products
  • 1.2 Types of IVD Tests
  • 1.3 Market Segments
    • 1.3.1 Technology Type
    • 1.3.2 End-User Segmentation
  • 1.4 Uses of IVDs
  • 1.5 IVD Value Chain

2. IVD Market Analysis

  • 2.1 Global Market
    • Market Value
    • Regional Breakdown
    • 2.1.1 IVD Market by Technology Type
    • 2.1.2 IVD Market by Product Type
    • 2.1.3 IVD Market by Test Location
  • 2.2 Molecular Diagnostics
    • 2.2.1 Molecular Diagnostic Market by Test Category
  • 2.3 Immunoassays
  • 2.4 Regional Markets
    • 2.4.1 Europe
      • Market Value
      • Market Share by Countries
    • 2.4.2 China

3. Market Dynamics

  • 3.1 Growth Drivers
    • 3.1.1 Rising Global Healthcare Expense
    • 3.1.2 Increasing Global Ageing Population
    • 3.1.3 Accelerating Global Diabetic Population
    • 3.1.4 Increasing Global Gross National Income
    • 3.1.5 Increasing Sales of Medical Technological Devices
    • 3.1.6 Increasing Complexity of Diseases
    • 3.1.7 Development of Cardiac Troponin Assays
  • 3.2 Key Trends
    • 3.2.1 Vitamin D Testing Market - New Growing Segment
    • 3.2.2 Illumina - Dominating the Genome Sequencing Market
    • 3.2.3 Increased Importance of Diagnostics
    • 3.2.4 Increased Usage of Companion Diagnostic in Oncology
  • 3.3 Challenges
    • 3.3.1 Diagnostic Market Containing Narrow Economic Moats
    • 3.3.2 More Diagnostic Regulation in Genetic Based Tests
    • 3.3.3 Laboratory-Developed Tests Waning IVD Profits
    • 3.3.4 Government Regulation for IVD Tests
    • 3.3.5 Coverage and Reimbursement of Clinical Laboratory Services

4. Competitive Landscape

  • 4.1 Global Market
  • 4.2 Competition by Segments
    • 4.2.1 Clinical Chemistry
    • 4.2.2 Blood Glucose Testing
    • 4.2.3 Microbiology
    • 4.2.4 Hematology and Flow Cytometry
    • 4.2.5 Molecular Diagnostic
    • 4.2.6 Immunoassay
    • 4.2.7 Tissue Diagnostic
  • 4.3 China

5. Company Profiles

  • 5.1 Abbott Laboratories
    • 5.1.1 Business Overview
    • 5.1.2 Financial Overview
    • 5.1.3 Business Strategies
  • 5.2 Siemens AG
    • 5.2.1 Business Overview
    • 5.2.2 Financial Overview
    • 5.2.3 Business Strategies
  • 5.3 Roche Holdings AG
    • 5.3.1 Business Overview
    • 5.3.2 Financial Overview
    • 5.3.3 Business Strategies
  • 5.4 Johnson & Johnson
    • 5.4.1 Business Overview
    • 5.4.2 Financial Overview
    • 5.4.3 Business Strategies

6. Market Outlook

  • 6.1 Market Forecast
  • 6.2 Forecast Methodology
    • 6.2.1 Dependent and Independent Variables
    • 6.2.2 Correlation Analysis
    • 6.2.3 Regression Analysis

List of Charts

  • IVD Market Segments by Technology Type
  • IVD Market by End Users
  • IVD Value Chain Analysis in Medical Application
  • Global IVD Market Value (2009-2014)
  • Global IVD Market by Geography (2014)
  • Global In-Vitro Diagnostic Device Sales (2011-2014)
  • Global IVD Market Share by Technology Type (2014)
  • Global Clinical and Industrial In-Vitro Market Value (2011-2014)
  • Global Clinical IVD Market by Region (2014)
  • Global Clinical IVD Market by Technology Type (2014)
  • Global IVD Market Share by Product Type (2014)
  • Global IVD Instrumentation Market Share by Segment (2009-2015E)
  • Global IVD Market by Test Location (2014)
  • Global Molecular Diagnostic Market Value (2009-2018E)
  • Molecular Diagnostic Market Share by Test Category (2014)
  • Immunoassay Market Share by Clinical Areas (2014)
  • IVD Market Value in EU27+ EFTA (2009-2014)
  • IVD Market in Europe by Region (2013/2014)
  • IVD Market Share in Europe - by Countries (2014)
  • European IVD Market - by Countries (2014)
  • IVD Market Value in China (2009-2018E)
  • Global Healthcare Expenditure Per Capita (2009-2014E)
  • Global Aging Population Over 65 (2009-2014)
  • World Population with Diabetes, Age Group 20-79 years (2007-2014)
  • Global GDP - World & Regions (2009-2014)
  • Global GNI per Capita - World & Regions (2009-2014)
  • Global Medical Technology Sales (2005-2014)
  • Global IVD Market Share Breakdown by Company (2014)
  • Clinical Chemistry Market Share by Company (2014)
  • Blood Glucose Testing Market Share by Company (2014)
  • Microbiology Market Share by Company (2014)
  • Hematology and Flow Cytometry Market Share by Company (2014)
  • Hemostasis Market Share by Company (2014)
  • Molecular Diagnostic Market Share by Company (2014)
  • Immunoassay Market Share by Company (2014)
  • Immunoassay Infectious Disease Market Share by Company (2014)
  • Immunoassay Hepatitis/Retrovirus Market Share by Company (2014)
  • Immunoassay GI Stool Testing Market Share by Company (2014)
  • Immunoassay Onco/Endocrino-logy Market Share by Company (2014)
  • Immunoassay Nucleic Acid Test Market Share by Company (2014)
  • Tissue Diagnostic Market Share by Company (2014)
  • IVD Market Share by Company in China (2014E)
  • Abbott Laboratories Revenue Share by Business Segments (2014)
  • Abbott Laboratories Revenue and Net Income (2009-2014)
  • Siemens Revenue Share by Business Segments (2015)
  • Siemens Revenue and Net Income (2010-2015)
  • Roche's Revenue Share by Business Segments (2014)
  • Roche's Revenue and Net Income (2009-2014)
  • Revenue Share of Johnson & Johnson's by Business Segments (2014)
  • Revenues and Net Income of Johnson & Johnson (2009-2014)
  • Global In Vitro Diagnostics Market Value Forecast (2013-2020F)

List of Tables

  • IVD Market Key Players-by Segments
  • Country-wise Division of European IVD Market (2014)
  • Economic Moat Comparison by Healthcare Product Industry (2014)
  • Competitive Positioning in Molecular Diagnostic Segment (2014)
  • Dependent & Independent Variables (2009-2014)
  • Correlation Matrix
  • Model Summary - Coefficient of Determination
  • Regression Coefficients Output
Back to Top